Biofarm Bucuresti
2 articole · RSS
Companies
Biofarm's Net Profit Plunges 17% YoY To RON42M In H1/2024
Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first half of 2024 with net profit of RON42 million, down 17% from RON50.2 million reported in the same period of 2023, as per its half-yearly financial report.
Companies
Biofarm Plans to Double Turnover in 5-10 Years
Pharmaceutical manufacturer Biofarm Bucuresti plans to double turnover and focus more on exports in the coming years, according to Catalin Vicol, the company’s general manager.